Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia

scientific article

Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/NAU.20168
P698PubMed publication ID16304673

P2093author name stringA Riis
A Rembratt
J P Norgaard
P433issue2
P407language of work or nameEnglishQ1860
P921main subjectnocturiaQ1426443
desmopressinQ241006
hyponatremiaQ824292
P304page(s)105-9
P577publication date2006-01-01
P1433published inNeurourology and UrodynamicsQ15753354
P1476titleDesmopressin treatment in nocturia; an analysis of risk factors for hyponatremia
P478volume25

Reverse relations

cites work (P2860)
Q46041029A practical approach to the management of nocturia
Q34656572An overview of nocturia and the syndrome of nocturnal polyuria in the elderly
Q54613905Comparison of nocturia response to desmopressin treatment between patients with normal and high nocturnal bladder capacity index.
Q79813753Desmopressin : safety considerations in patients with chronic renal disease
Q42758215Desmopressin for nocturia in the old: an inappropriate treatment due to the high risk of side-effects?
Q48252319Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial
Q33843159Early Intranasal Vasopressin Administration Impairs Partner Preference in Adult Male Prairie Voles (Microtus ochrogaster).
Q35070018Effect of desmopressin with anticholinergics in female patients with overactive bladder
Q48508331Efficacy of adding behavioural treatment or antimuscarinic drug therapy to α-blocker therapy in men with nocturia
Q38200832Etiology, evaluation, and management of nocturia in elderly men and women
Q51497693Gender difference in antidiuretic response to desmopressin.
Q47713249Increased Urine Production Due to Leg Fluid Displacement Reduces Hours of Undisturbed Sleep
Q43125223Is there still a role for desmopressin in children with primary monosymptomatic nocturnal enuresis?: a focus on safety issues
Q39174592Low-dose desmopressin combined with serum sodium monitoring can prevent clinically significant hyponatraemia in patients treated for nocturia
Q37811494Major Urologic Problems in Geriatrics: Assessment and Management
Q90502778Management of Nocturia and Nocturnal Polyuria
Q38246710Managing urinary incontinence: what works?
Q88266792Nocturia
Q37993502Nocturia Think Tank: focus on nocturnal polyuria: ICI-RS 2011.
Q37847640Nocturia as a manifestation of systemic disease
Q38907923Nocturia: aetiology and treatment in adults
Q38049167Nocturia: current concepts and future perspectives
Q64082338Pharmacokinetic and Pharmacodynamic Properties of a Micro-Dose Nasal Spray Formulation of Desmopressin (AV002) in Healthy Water-Loaded Subjects
Q50089352Pharmacotherapy for Nocturia
Q37197789Practical management of nocturia in urology
Q88636789Practical points in the medical treatment of overactive bladder and nocturia in the elderly
Q40215593Preliminary Experience with Low-dose Desmopressin Treatment and Urinary Arginine Vasopressin Concentration as a Response Predictor for Patients with Nocturia with Nocturnal Polyuria
Q38013154Recent patenting activities in the discovery and development of vasopressin V2 receptor agonists
Q48317678Reducing nocturia in the elderly: a randomized placebo-controlled trial of staggered furosemide and desmopressin
Q83400024Relationship between nocturnal urine volume, leg edema, and urinary antidiuretic hormone in older men
Q42573265Short term effect and safety of antidiuretic hormone in the patients with nocturia
Q55486735The Management of Lower Urinary Tract Dysfunction in Multiple Sclerosis.
Q38077543The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy
Q36349753The dilemma of nocturia
Q37884579Urinary incontinence: pharmacotherapy options
Q46818576Use of desmopressin and concomitant use of potentially interacting drugs in elderly patients in Sweden

Search more.